Indian Journal of Dermatology, Venereology and Leprology
Medknow Publications on behalf of The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL)
Vol. 72, No. 5, 2006, pp. 373-375
Bioline Code: dv06126
Full paper language: English
Document type: Research Article
Document available free of charge
Indian Journal of Dermatology, Venereology and Leprology, Vol. 72, No. 5, 2006, pp. 373-375
© Copyright 2006 Indian Journal of Dermatology, Venereology and Leprology.
Case Report-Superficial basal cell carcinoma on face treated with 5% imiquimod cream|
Malhotra AmitKumar, Bansal Arika, Mridha AsitR, Khaitan BinodK, Verma KaushalK
Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.
Basal cell carcinoma, Imiquimod, Treatment
Alternative site location: http://www.ijdvl.com